TransMedics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $189,948 | $173,933 | $160,764 | $143,823 |
Gross Profit | 113,198 | 101,161 | 93,414 | 84,575 |
EBITDA | 26,630 | 27,519 | 32,455 | 33,371 |
EBIT | 15,655 | 24,987 | 26,522 | |
Net Income | 14,682 | 7,315 | 105,383 | 24,319 |
Net Change In Cash | 189,948 | 173,933 | 160,764 | 143,823 |
Free Cash Flow | 10,217 | -12,124 | 18,999 | 61,949 |
Cash | 472,675 | 461,739 | 488,366 | 466,174 |
Basic Shares | 40,709 | 36,194 | 40,927 | 40,748 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $605,494 | $441,540 | $241,623 | $93,459 |
Gross Profit | 362,806 | 262,081 | 154,093 | 65,272 |
EBITDA | 148,489 | 69,947 | -7,703 | -28,961 |
EBIT | 121,304 | 50,189 | -15,880 | -32,439 |
Net Income | 190,291 | 35,464 | -25,028 | -36,231 |
Net Change In Cash | 605,494 | 441,540 | 241,623 | 93,459 |
Free Cash Flow | 133,589 | -80,941 | -192,087 | -57,724 |
Cash | 488,366 | 336,650 | 394,812 | 201,182 |
Basic Shares | 40,540 | 35,217 | 32,517 | 29,556 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.44 |
2026-03-31 | $0.30 |
2025-12-31 | $0.05 |
2025-09-30 | $0.66 |